Phathom Pharmaceuticals, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
PHAT Company Description
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
PHAT Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view PHAT Smart Score
Score Breakdown
PHAT Company Description
Show More
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of PHAT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PHAT's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on PHAT's company Twitter account
WallStreetBets
Number of mentions of PHAT in WallStreetBets Daily Discussion
PHAT News
Recent insights relating to PHAT
CNBC Recommendations
Recent picks made for PHAT stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in PHAT
Corporate Flights
Flights by private jets registered to PHAT
Our Analysis